KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $463.0 million.

  • Medpace Holdings' Cost of Revenue rose 2708.0% to $463.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 1158.47%. This contributed to the annual value of $1.5 billion for FY2024, which is 671.49% up from last year.
  • Latest data reveals that Medpace Holdings reported Cost of Revenue of $463.0 million as of Q3 2025, which was up 2708.0% from $423.3 million recorded in Q2 2025.
  • Medpace Holdings' 5-year Cost of Revenue high stood at $463.0 million for Q3 2025, and its period low was $181.5 million during Q1 2021.
  • Over the past 5 years, Medpace Holdings' median Cost of Revenue value was $336.6 million (recorded in 2023), while the average stood at $311.7 million.
  • Per our database at Business Quant, Medpace Holdings' Cost of Revenue soared by 3726.39% in 2021 and then plummeted by 91.9% in 2024.
  • Medpace Holdings' Cost of Revenue (Quarter) stood at $220.6 million in 2021, then increased by 26.2% to $278.4 million in 2022, then rose by 29.9% to $361.6 million in 2023, then dropped by 0.92% to $358.3 million in 2024, then increased by 29.22% to $463.0 million in 2025.
  • Its last three reported values are $463.0 million in Q3 2025, $423.3 million for Q2 2025, and $380.2 million during Q1 2025.